| dc.contributor.author | López Suárez, Patricia | |
| dc.contributor.author | Gutiérrez Martín, María del Carmen | |
| dc.contributor.author | Suárez Díaz, Ana María | |
| dc.date.accessioned | 2013-01-30T10:06:34Z | |
| dc.date.available | 2013-01-30T10:06:34Z | |
| dc.date.issued | 2008 | |
| dc.identifier.citation | Clinical Immunology, 129(2), p. 350-359 (2008); doi:10.1016/j.clim.2008.07.010 | spa |
| dc.identifier.issn | 1521-6616 | |
| dc.identifier.issn | 1090-2341 | |
| dc.identifier.uri | http://hdl.handle.net/10651/8156 | |
| dc.description.sponsorship | This study was supported by Grant FIS PI 052409 from the Fondo de Investigaciones Sanitarias. Patricia López was supported by a grant from the Fundación Eugenio Rodríguez Pascual. | |
| dc.format.extent | p. 350-359 | spa |
| dc.language.iso | eng | |
| dc.relation.ispartof | Clinical Immunology | spa |
| dc.rights | © 2008 Elsevier Inc | |
| dc.source | WOK | spa |
| dc.title | IFN alpha treatment generates antigen-presenting cells insensitive to atorvastatin inhibition of MHC-II expression | spa |
| dc.type | journal article | |
| dc.identifier.local | 363 | spa |
| dc.identifier.doi | 10.1016/j.clim.2008.07.010 | |
| dc.relation.projectID | FIS/PI/052409 | |
| dc.relation.publisherversion | http://dx.doi.org/10.1016/j.clim.2008.07.010 | spa |
